TSPO and multiple sclerosis: Recently, Sridharan and co-workers confirmed specific binding of 18F-GE-180 in humans by a blocking study in patients with multiple sclerosis showing that in HAB subjects about 57% of VT represent specific binding of 18F-GE-180 to the TSPO [50].